Parkinson´s disease (PD) patients often receive combined pharmacotherapies where D2-class dopamine agonists are used as an adjunct to L-DOPA. We have now investigated the effects of this adjunct treatment at multiple levels and obtained some intriguing results…read the entire story in this paper:
Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa-Induced Dyskinesia.
Espa E, Song L, Skovgård K, Fanni S, Cenci MA. Mov Disord. 2023 Jan 19. doi: 10.1002/mds.29301. Online ahead of print.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.